Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials.
Arechavala-Gomeza V, Kinali M, Feng L, Guglieri M, Edge G, Main M, Hunt D, Lehovsky J, Straub V, Bushby K, Sewry CA, Morgan JE, Muntoni F.
Arechavala-Gomeza V, et al. Among authors: morgan je.
Neuromuscul Disord. 2010 May;20(5):295-301. doi: 10.1016/j.nmd.2010.03.007. Epub 2010 Apr 14.
Neuromuscul Disord. 2010.
PMID: 20395141
Free article.